Labor and Delivery Doula Program to Reduce Perinatal Morbidity and Mortality in Kansas

NCT ID: NCT07157059

Last Updated: 2025-09-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-12

Study Completion Date

2024-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study was done to learn how doula-enhanced care provided to Black birthing people improved perceived communication and quality care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy Related Doula Care Black Maternal and Infant Health Prenatal Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Doula-Enhanced Care Group

This group received doula-enhanced care along with routine pregnancy care.

Group Type EXPERIMENTAL

Doula Care

Intervention Type BEHAVIORAL

Participants assigned to the Doula care group received care from the doula pre, during, and post delivery.

Routine Pregnancy Care Group

This group received routine pregnancy care.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Doula Care

Participants assigned to the Doula care group received care from the doula pre, during, and post delivery.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Black birthing people
* Received care and plan to delivery at the University of Kansas Medical Center
* Scored positive to social determinants of health screener
* Gestational age between 14-27.6 weeks at enrollment

Exclusion Criteria

* Pregnancy not viable or pregnancy not intrauterine on ultrasound
* Patients who are not willing to be randomized into not receiving doula enhanced
* Patients who do not plan to delivery at the University of Kansas Health System
* Non-Black birthing people.
* Planned cesarean section
* Patients with a known major fetal anomaly
* Non-English speaking
Minimum Eligible Age

16 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

BioNexus KC

UNKNOWN

Sponsor Role collaborator

Blue KC (Blue Cross Blue Shield)

UNKNOWN

Sponsor Role collaborator

University of Kansas Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Angela Martin, MD

Role: PRINCIPAL_INVESTIGATOR

University of Kansas Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Kansas Medical Center

Kansas City, Kansas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FP00000002

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

IRB STUDY00149318

Identifier Type: OTHER

Identifier Source: secondary_id

STUDY00161314

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Melanated Group Midwifery Care (MGMC)
NCT05365815 RECRUITING NA
Healthy Mothers on the Move
NCT01584063 COMPLETED NA